Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug-Receptor Bonds01:25

Drug-Receptor Bonds

5.3K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
5.3K
Ligand Binding Sites02:40

Ligand Binding Sites

9.1K
9.1K
Ligand Binding Sites02:40

Ligand Binding Sites

15.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.7K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

4.7K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.7K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

8.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.3K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

19.5K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
19.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Structure-Activity-Relationship Study of Potent G2A Antagonists.

Journal of medicinal chemistry·2026
Same author

Ethological profiling defines pain behaviors and parses analgesia from drug side effects in a mouse model of complex regional pain syndrome.

Pain·2026
Same author

Dopamine, γ-aminobutyric acid, and glutamate balance in the nucleus accumbens shell: Differential effects of cannabinoid 1 receptor agonists Δ<sup>9</sup>-Tetrahydrocannabinol, AM11101, and AM8936.

Neuropharmacology·2026
Same author

Large Library Docking for Polypharmacology.

Journal of medicinal chemistry·2026
Same author

Associations of dementia polyexposure scores to Alzheimer's disease endophenotypes in diverse populations.

medRxiv : the preprint server for health sciences·2026
Same author

Click Chemistry-Enabled Parallel Synthesis of <i>N</i>-Acyl Sulfonamides and Their Evaluation as Carbonic Anhydrase Inhibitors.

Molecules (Basel, Switzerland)·2026
Same journal

Layered social competition coordinates reproductive hierarchy formation in ants.

bioRxiv : the preprint server for biology·2026
Same journal

Combination epigenetic-targeted therapy increases the immunogenicity of poorly immunogenic sarcomas.

bioRxiv : the preprint server for biology·2026
Same journal

Loss of LanC-like proteins delays post-injury regeneration of aging skeletal muscles.

bioRxiv : the preprint server for biology·2026
Same journal

Integrative Transfer Network: Deep Transfer Learning Across Populations and Prediction Targets.

bioRxiv : the preprint server for biology·2026
Same journal

Confidence-supported label-free metabolic imaging with FPhaS phase autofluorescence microscopy.

bioRxiv : the preprint server for biology·2026
Same journal

Sequence-encoded autoinhibition couples mRNA decapping activity to phase separation.

bioRxiv : the preprint server for biology·2026
See all related articles

Related Experiment Video

Updated: Mar 28, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

1.3K

Library docking for Cannabinoid-2 Receptor ligands.

Moira M Rachman1, Christos Iliopoulos-Tsoutsouvas2, Michael D Sacco3

  • 1Department of Pharmaceutical Chemistry, University of California San Francisco, 1700 4th St., Byers Hall Rm 508D, San Francisco, CA 94143.

Biorxiv : the Preprint Server for Biology
|March 27, 2026
PubMed
Summary
This summary is machine-generated.

Researchers discovered novel, highly potent cannabinoid receptor 2 (CB2) ligands using structure-based drug design. Targeting specific receptor interactions yielded subtype-selective compounds, advancing therapeutic potential.

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.5K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K

Related Experiment Videos

Last Updated: Mar 28, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

1.3K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.5K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K

Area of Science:

  • Medicinal Chemistry
  • Structural Biology
  • Pharmacology

Background:

  • G protein-coupled receptors (GPCRs), including cannabinoid receptors, are key therapeutic targets.
  • Structure-based drug design offers a powerful approach for targeting GPCRs.
  • Previous efforts targeting the CB1 receptor yielded potent but non-selective ligands.

Purpose of the Study:

  • To explore library docking strategies using the CB2 receptor as a model system.
  • To identify subtype-selective ligands for the CB2 receptor.
  • To investigate the impact of library size and receptor state on docking outcomes.

Main Methods:

  • Structure-based drug design utilizing the CB2 receptor crystal structure.
  • Large-scale virtual screening (library docking) of up to 2.6 billion molecules.
  • Cryo-electron microscopy (Cryo-EM) for structural validation.
  • Structure-based optimization of identified ligands.

Main Results:

  • Targeting polar, orthosteric residues of CB2 led to subtype-selective ligands.
  • Increased library size significantly improved docking hit rate and ligand affinity.
  • Docking against different receptor states did not reliably predict agonist or inverse agonist activity.
  • Cryo-EM structures confirmed the accuracy of docking predictions for novel agonists.
  • Structure-based optimization yielded substantial potency improvements (10-140 fold).
  • Eight diverse ligand families with nanomolar potency were discovered.

Conclusions:

  • Structure-based design targeting specific interactions is effective for discovering selective GPCR ligands.
  • Large virtual libraries are crucial for identifying high-affinity compounds.
  • The CB2 receptor remains a viable target for developing novel therapeutics.
  • This study provides a framework for future structure-based drug discovery campaigns against GPCRs.